FXNCX
Price
$10.14
Change
-$0.00 (-0.00%)
Updated
Jun 20 closing price
Net Assets
564.58M
MPGOX
Price
$8.81
Change
-$0.00 (-0.00%)
Updated
Jun 20 closing price
Net Assets
105.97M
Interact to see
Advertisement

FXNCX vs MPGOX

Header iconFXNCX vs MPGOX Comparison
Open Charts FXNCX vs MPGOXBanner chart's image
Franklin NC Tax-Free Income A1
Price$10.14
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets564.58M
MFS GA Municipal Bond R6
Price$8.81
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets105.97M
FXNCX vs MPGOX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FXNCX vs. MPGOX commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXNCX is a Hold and MPGOX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FXNCX has more cash in the bank: 565M vs. MPGOX (106M). MPGOX pays higher dividends than FXNCX: MPGOX (3.39) vs FXNCX (2.95). FXNCX was incepted earlier than MPGOX: FXNCX (38 years) vs MPGOX (8 years). FXNCX (0.70) and MPGOX (0.68) have similar cost to investors . MPGOX is a more actively managed with annual turnover of: 20.00 vs. FXNCX (10.28). MPGOX has a lower initial minimum investment than FXNCX: MPGOX (0) vs FXNCX (1000). MPGOX annual gain was more profitable for investors over the last year : -0.50 vs. FXNCX (-0.72). MPGOX return over 5 years is better than : 1.97 vs. FXNCX (-5.24).
FXNCXMPGOXFXNCX / MPGOX
Total Expense Ratio0.700.60117%
Annual Report Gross Expense Ratio0.700.68103%
Fund Existence38 years8 years-
Gain YTD-1.869-2.02292%
Front Load4%N/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets565M106M533%
Annual Yield % from dividends2.953.3987%
Returns for 1 year-0.72-0.50144%
Returns for 3 years5.817.7775%
Returns for 5 years-5.241.97-266%
Returns for 10 years-4.73N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGIFX85.110.10
+0.12%
JPMorgan US Value R5
SCAVX13.65N/A
N/A
AB Small Cap Value A
MVISX43.19N/A
N/A
Patient Opportunity IS
FISGX39.46-0.12
-0.30%
Nuveen Small/Mid Cap Growth Opp I
RYWVX69.86-1.66
-2.32%
Rydex Emerging Markets 2X Strategy H